- Home
- LXEO vs HCIC Comparison
LXEO vs HCIC Comparison
Compare LXEO & HCIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Company Overview
Basic Information| Metric | LXEO | HCIC |
|---|---|---|
| Founded | 2017 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | |
| Sector | | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 387.1M | 352.6M |
| IPO Year | 2023 | 2026 |
Fundamental Metrics
Financial Performance| Metric | LXEO | HCIC |
|---|---|---|
| Price | $4.69 | $9.94 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 9 | 0 |
| Target Price | ★ $18.44 | N/A |
| AVG Volume (30 Days) | ★ 803.0K | 3.2K |
| Earning Date | 05-06-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 39.81 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $654,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $3.60 | $9.93 |
| 52 Week High | $10.99 | $9.97 |
Technical Indicators
Market Signals| Indicator | LXEO | HCIC |
|---|---|---|
| Relative Strength Index (RSI) | 47.57 | N/A |
| Support Level | $4.44 | N/A |
| Resistance Level | $5.34 | N/A |
| Average True Range (ATR) | 0.35 | 0.00 |
| MACD | 0.08 | 0.00 |
| Stochastic Oscillator | 57.25 | 0.00 |
Price Performance
Historical Comparison LXEO
HCIC
About LXEO Lexeo Therapeutics Inc.
Lexeo Therapeutics Inc is a clinical-stage genetic medicine company engaged in the development of gene therapy candidates targeting the underlying genetic causes of cardiovascular diseases. The company is advancing a portfolio of programs focused on conditions such as Friedreich ataxia, cardiomyopathy, plakophilin-2, or PKP2, and arrhythmogenic cardiomyopathy, with its lead candidates including LX2006 and LX2020. Its therapies utilize AAV-based vectors designed to deliver functional genes to cardiac cells to restore normal function and address high unmet medical needs.
About HCIC Hennessy Capital Investment Corp. VIII Class A Ordinary Shares
Hennessy Capital Investment Corp VIII is a blank check company.